![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
Departments of
* Molecular Physiology and Biophysics, and
Psychiatry, Vanderbilt University, Nashville, TN and
** Human Biology and Nutritional Sciences, University of Guelph, Guelph, Canada.
2To whom correspondence should be addressed. E-mail: jane.shearer{at}vanderbilt.edu.
Consumption of large amounts of coffee has been shown to decrease the incidence of type 2 diabetes. However, the specific compounds and mechanisms responsible for this effect are not known. The aim of this study was to determine the effects of a decaffeinated coffee extract and a synthetic quinide, representative of those found in roasted coffee, 3,4-diferuloyl-1,5-quinolactone, on insulin-stimulated glucose disposal and muscle glucose uptake. Experiments were performed on conscious rats during hyperinsulinemic, euglycemic clamps receiving gastric infusions of saline, a decaffeinated coffee extract (DECAF) (220 mg/kg), or 3,4-diferuloyl-1,5-quinide (DIFEQ) (110 mg/kg). Following treatment, rats received an intravenous bolus of deoxy-[2-3H] glucose to assess muscle glucose uptake (Rg, µmol · 100 g-1 · min-1). Glucose infusions [mg/(kg · min)] required to maintain euglycemia during the tracer period were higher with DIFEQ (14.6 ± 0.7) than with saline (10.8 ± 0.7) and DECAF (11.5 ± 1.1). Despite increased glucose requirements, Rg in skeletal (soleus, gastrocnemius, superficial vastus lateralis) and cardiac muscle were unchanged. DECAF or DIFEQ did not affect heart rate, blood pressure, plasma nonesterified fatty acids or liver aminotransferase activity. These results demonstrate that DIFEQ increases whole-body glucose disposal independently of skeletal muscle Rg.
KEY WORDS: • skeletal muscle glucose uptake • chlorogenic acid • diabetes • metabolism
This article has been cited by other articles:
|
|
 |
|
  A. Farah, M. Monteiro, C. M. Donangelo, and S. Lafay Chlorogenic Acids from Green Coffee Extract are Highly Bioavailable in Humans J. Nutr., December 1, 2008; 138(12): 2309 - 2315. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. O Odegaard, M. A Pereira, W.-P. Koh, K. Arakawa, H.-P. Lee, and M. C Yu Coffee, tea, and incident type 2 diabetes: the Singapore Chinese Health Study Am. J. Clinical Nutrition, October 1, 2008; 88(4): 979 - 985. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. M. van Dam Coffee Consumption and Coronary Heart Disease: Paradoxical Effects on Biological Risk Factors versus Disease Incidence Clin. Chem., September 1, 2008; 54(9): 1418 - 1420. [Full Text] [PDF]
|
|
|
|
 |
|
 S. C. Larsson, S. Mannisto, M. J. Virtanen, J. Kontto, D. Albanes, and J. Virtamo Coffee and Tea Consumption and Risk of Stroke Subtypes in Male Smokers Stroke, June 1, 2008; 39(6): 1681 - 1687. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. L Moisey, S. Kacker, A. C Bickerton, L. E Robinson, and T. E Graham Caffeinated coffee consumption impairs blood glucose homeostasis in response to high and low glycemic index meals in healthy men Am. J. Clinical Nutrition, May 1, 2008; 87(5): 1254 - 1261. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. M. McLellan How Does Caffeine Increase Exercise Capacity But Decrease Myocardial Flow Reserve? J. Am. Coll. Cardiol., December 5, 2006; 48(11): 2355 - 2356. [Full Text] [PDF]
|
|
|
|
 |
|
 B. Smith, D. L. Wingard, T. C. Smith, D. Kritz-Silverstein, and E. Barrett-Connor Does coffee consumption reduce the risk of type 2 diabetes in individuals with impaired glucose? Diabetes Care, November 1, 2006; 29(11): 2385 - 2390. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A Greenberg, C. N Boozer, and A. Geliebter Coffee, diabetes, and weight control. Am. J. Clinical Nutrition, October 1, 2006; 84(4): 682 - 693. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. S. Battram, R. Arthur, A. Weekes, and T. E. Graham The Glucose Intolerance Induced by Caffeinated Coffee Ingestion Is Less Pronounced than That Due to Alkaloid Caffeine in Men J. Nutr., May 1, 2006; 136(5): 1276 - 1280. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. M. van Dam, W. C. Willett, J. E. Manson, and F. B. Hu Coffee, Caffeine, and Risk of Type 2 Diabetes: A prospective cohort study in younger and middle-aged U.S. women Diabetes Care, February 1, 2006; 29(2): 398 - 403. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. M. van Dam and F. B. Hu Coffee Consumption and Development of Type 2 Diabetes--Reply JAMA, November 9, 2005; 294(18): 2299 - 2299. [Full Text] [PDF]
|
|
|
|
|
|
R. M. van Dam and F. B. Hu Coffee Consumption and Risk of Type 2 Diabetes: A Systematic Review JAMA, July 6, 2005; 294(1): 97 - 104. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Lee, R. Hudson, K. Kilpatrick, T. E. Graham, and R. Ross Caffeine Ingestion Is Associated With Reductions in Glucose Uptake Independent of Obesity and Type 2 Diabetes Before and After Exercise Training Diabetes Care, March 1, 2005; 28(3): 566 - 572. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. R. Pencek, D. Battram, J. Shearer, F. D. James, D. B. Lacy, K. Jabbour, P. E. Williams, T. E. Graham, and D. H. Wasserman Portal Vein Caffeine Infusion Enhances Net Hepatic Glucose Uptake during a Glucose Load in Conscious Dogs J. Nutr., November 1, 2004; 134(11): 3042 - 3046. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. E. Robinson, S. Savani, D. S. Battram, D. H. McLaren, P. Sathasivam, and T. E. Graham Caffeine Ingestion Before an Oral Glucose Tolerance Test Impairs Blood Glucose Management in Men with Type 2 Diabetes J. Nutr., October 1, 2004; 134(10): 2528 - 2533. [Abstract] [Full Text] [PDF]
|
|
